The association between intraoperative cardiopulmonary bypass power and complications after cardiac surgery

被引:0
|
作者
Hui, Victor [1 ,2 ,7 ]
Ho, Kwok M. [3 ,4 ]
Hahn, Rebecca [2 ]
Wright, Brian [5 ]
Larbalestier, Robert [6 ]
Pavey, Warren [2 ,5 ]
机构
[1] Royal Melbourne Hosp, Dept Anaesthesia & Pain Med, Melbourne, Vic, Australia
[2] Heart Lung Res Inst Western Australia, Perth, WA, Australia
[3] Univ Western Australia, Med Sch, Perth, WA, Australia
[4] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia
[5] Fiona Stanley Hosp, Dept Anaesthesia Pain & Perioperat Med, Perth, WA, Australia
[6] Fiona Stanley Hosp, Dept Cardiothorac Surg, Perth, WA, Australia
[7] Royal Melbourne Hosp, Dept Anaesthesia & Pain Management, 300 Grattan St, Parkville, Vic 3050, Australia
来源
PERFUSION-UK | 2023年
关键词
PERFUSION-PRESSURE; HYPOTENSION; DYSFUNCTION; FLOW;
D O I
10.1177/02676591231187958
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Low cardiac power (product of flow and pressure) has been shown to be associated with mortality in patients with cardiogenic shock after acute myocardial infarction, but has not been studied in cardiac surgical patients. This study's hypothesis was that cardiac power during cardiopulmonary bypass for cardiac surgery would have a greater association with adverse events than either flow or MAP (mean arterial pressure) alone. Methods We undertook a retrospective observational study using patient data from February 2015 to March 2022 undergoing cardiac surgery at Fiona Stanley Hospital in Perth Australia. Excluded were patient age less than 18 years old, patients undergoing thoracic transplantation, ventricular assist devices, off pump cardiac surgery and aortic surgery. The primary outcome was a composite outcome of 30-days mortality, stroke or new-onset renal insufficiency. Results Overall, 1984 cardiac surgeries were included in the analysis. Neither duration nor area below thresholds tested for power, MAP or flow was associated with the primary composite outcome. However, we found that an area below MAP thresholds 35-50 mmHg was associated with new renal insufficiency (adjusted odds ratio 1.17 [95% CI 1.02 to 1.35] for patients spending 10 min at 10 mmHg below 50 mmHg MAP compared to those who did not). Conclusions This study suggests that MAP during cardiopulmonary bypass, but not power or flow, was an independent risk factor for adverse renal outcomes for cardiac surgical patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] ABDOMINAL COMPLICATIONS AFTER CARDIAC-SURGERY WITH CARDIOPULMONARY BYPASS
    WIDERA, R
    LINDENAU, KF
    PREHL, J
    GROSSMANN, M
    [J]. ZENTRALBLATT FUR CHIRURGIE, 1990, 115 (14): : 885 - 891
  • [2] Cardiopulmonary bypass is the main predictor of gastrointestinal complications after cardiac surgery
    Raja, SG
    Haider, Z
    Ahmad, M
    [J]. TEXAS HEART INSTITUTE JOURNAL, 2004, 31 (01) : 108 - 108
  • [3] Association of intraoperative hyperglycemia with postoperative composite infection after cardiac surgery with cardiopulmonary bypass: A retrospective cohort study
    Xiong, Xinglong
    Chen, Dongxu
    Cai, Shuang
    Qiu, Li
    Shi, Jing
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 9
  • [4] Cardiopulmonary resuscitation with cardiopulmonary bypass after cardiac surgery
    I Rodrigus
    BJ Amsel
    B Stockman
    R De Paep
    AC Moulijn
    [J]. Critical Care, 4 (Suppl 1):
  • [5] Postoperative complications following cardiac surgery with cardiopulmonary bypass
    DM Atwell
    I Welsby
    WD White
    SA King
    MG Mythen
    [J]. Critical Care, 1 (Suppl 1):
  • [6] Association between intraoperative blood salvage and coagulation disorder after cardiopulmonary bypass
    Morinaga, Masahiro
    Yoshitani, Kenji
    Ogata, Soshiro
    Fukushima, Satsuki
    Matsuda, Hitoshi
    [J]. JA CLINICAL REPORTS, 2024, 10 (01)
  • [7] Association between intraoperative blood salvage and coagulation disorder after cardiopulmonary bypass
    Masahiro Morinaga
    Kenji Yoshitani
    Soshiro Ogata
    Satsuki Fukushima
    Hitoshi Matsuda
    [J]. JA Clinical Reports, 10
  • [8] Intraoperative Vancomycin Pharmacokinetics in Cardiac Surgery With or Without Cardiopulmonary Bypass
    Cotogni, Paolo
    Passera, Roberto
    Barbero, Cristina
    Gariboldi, Angela
    Moscato, Donatella
    Izzo, Gennaro
    Rinaldi, Mauro
    [J]. ANNALS OF PHARMACOTHERAPY, 2013, 47 (04) : 455 - 463
  • [9] The Association Between Hypophosphatemia and Lactic Acidosis After Cardiac Surgery With Cardiopulmonary Bypass: A Retrospective Cohort Study
    Steck, Dominik T.
    Jelacic, Srdjan
    Mostofi, Nicki
    Wu, David
    Wells, Lauren
    Fong, Christine T.
    Cain, Kevin C.
    Sheu, Richard D.
    Togashi, Kei
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2023, 37 (03) : 374 - 381
  • [10] Association between inflammatory genetic polymorphism and acute lung injury after cardiac surgery with cardiopulmonary bypass
    Wang, Jia-feng
    Bian, Jin-jun
    Wan, Xiao-jian
    Zhu, Ke-ming
    Sun, Zhen-zhen
    Lu, An-dong
    [J]. MEDICAL SCIENCE MONITOR, 2010, 16 (05): : CR260 - CR265